 SUNNYVALE, Calif., Feb. 17, 2022 GLOBE NEWSWIRE -- 23andMe Holding Co. Nasdaq: ME 23andMe, a leading consumer genetics and research company with a mission to help people access, understand, and benefit from the human genome, announced today that management will be presenting at the Citi 2022 Virtual Healthcare Conference on February 24, 2022 at 1:15 pm Eastern Time. 